Skip to main content
FinSpry Logo
FinSpry
ZNTL logo
ZNTL
(NASDAQ)
Zentalis Pharmaceuticals, Inc.
$2.63-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Zentalis Pharmaceuticals (ZNTL) Stock Price & Financial Analysis

Zentalis Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.39 - $2.70
52-Week High$3.95
52-Week Low$1.01
Open$2.48
Volume358.12K
Average Volume (3M)358.12K
Market Cap189.73M
Shares Outstanding72.14M
Price to Sales (P/S)6.90
Price to Book (P/B)0.73
EV/EBITDA-1.20
Revenue (TTM)26.86M
Net Income (TTM)-149.32M
EPS (TTM)$-2.07
Profit Margin-555.80%
Operating Margin-572.24%
Return on Equity (ROE)-59.05%
Debt to Equity0.15
50-Day MA$2.54
200-Day MA$1.81
52-Week Change84.89%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Zentalis Pharmaceuticals

What is the current stock price for ZNTL?

As of the latest trading session, ZNTL stock trades at $2.63. The 52-week range is $1.01–$3.95, with a day range of $2.39–$2.70.

What is the P/E ratio for ZNTL?

The P/E ratio (Price-to-Earnings) for ZNTL is shown in the Key Statistics section. This valuation metric helps compare Zentalis Pharmaceuticals, Inc. to industry peers.

Does ZNTL pay dividends?

Zentalis Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ZNTL?

Based on 1 analyst, the consensus for ZNTL is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ZNTL?

Zentalis Pharmaceuticals's market capitalization is $189.7M, classifying it as a micro-cap company. Zentalis Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.